L. Antalgiques-de-palier and I. , 22 1.2.3.1 La morphine, p.24

. Sfap, La constipation sous opioïdes, 2008.

I. La-douleur and . Inserm, En ligne] [Citation : 22 11 2013

O. Oncolologik, [En ligne] [Citation : 23 11 2013

J. Bonnefont, A. Alloui, E. Chapuy, E. Clottes, and A. Eschalier, Orally Administered Paracetamol Does Not Act Locally in the Rat Formalin Test, Anesthesiology, vol.99, issue.4, 2003.
DOI : 10.1097/00000542-200310000-00034

M. Hadengue, A. Seirafi, and A. Iten, Paracétamol : toxicité hépatique aux doses thérapeutiques et populations à risque. Revue Médicale Suisse, p.129, 2007.

L. Schmidt, K. Dalhoff, and H. Poulsen, Acute versus chronic alcohol consumption in acetaminophen-induced hepatotoxicity. s.l. : Hepatology, pp.876-82, 2002.

. Faculté-de-médecine-de-strasbourg, Les anti-inflammatoires non-steroidiens

H. Thierry, Traitement par néfopam des douleurs abdominales de l'adulte en médecine ambulatoire d'urgence par les praticiens de SOS Médecins 54 : Enquête de pratiques sur l'utilisation des voies injectable et sub-linguale, p.114, 2009.

. Haute-autorité-de-santé, Commission de la transparence néfopam, HAS. [En

M. Sobczak, M. Sa?aga, M. Storr, and J. Fichna, Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives, Journal of Gastroenterology, vol.70, issue.2, pp.92-215, 2013.
DOI : 10.1002/ana.22446

H. Autorité and D. Santé, Les médicaments des accès douloureux paroxystiques du cancer. HAS santé. [En ligne] Septembre 2011. [Citation : 22 Décembre 2013

. Vidal and . Vidal, Breakyl®. www.vidal.fr. [En ligne] 18 04 2013. [Citation : 23 01, 2014.

. Pallialine, Misselijkeid en braken. pallialine.be. [En ligne] [Citation : 09 11 2013

J. Laulin, P. Maurette, J. Corcuff, C. Rivat, M. Chauvin et al., The Role of Ketamine in Preventing Fentanyl-Induced Hyperalgesia and Subsequent Acute Morphine Tolerance, s.l. : Anesthesia and analgesia, 2002.
DOI : 10.1097/00000539-200205000-00040

D. Center, . Evaluation, and . Research, Clinical Pharmacology Review of RELISTOR. s.l. : FDA, pp.21-964, 2007.

D. Lin, C. Wang, L. Qin, X. Xie, J. Wang et al., Bioavailability of oral methylnaltrexone increases with a phosphatidylcholine-based formulation. s.l. : Drug Dev Ind Pharm, 2013.

A. European-medicine, European Public Assessment Report of RELISTOR. [En ligne] 05 08 [Citation : 12 01 2014, 2009.

J. Thomas, S. Karver, G. Cooney, B. Chamberlain, C. Watt et al., Methylnaltrexone for Opioid-Induced Constipation in Advanced Illness, New England Journal of Medicine, vol.358, issue.22, 2008.
DOI : 10.1056/NEJMoa0707377

B. Candy, L. Jones, M. Goodman, R. Drake, and A. Tookman, Laxatives or methylnaltrexone for the management of constipation in palliative care patients. s.l. : The Cochrane database of systematic reviews, 2011.

H. Autorité-de-santé, Comission de transparence. HAS-Santé

T. Bell, S. Panchal, C. Miaskowski, S. Bolge, T. Milanova et al., The Prevalence, Severity, and Impact of Opioid-Induced Bowel Dysfunction: Results of a US and European Patient Survey (PROBE 1), Pain Medicine, vol.61, issue.1, 2009.
DOI : 10.12968/bjon.2006.15.4.20542

A. Tuteja, J. Biskupiak, G. Stoddard, and A. Lipman, Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain, Neurogastroenterology & Motility, vol.101, issue.4, pp.4-424, 2010.
DOI : 10.7326/0003-4819-101-3-331

N. Sykes, The relationship between opioid use and laxative use in terminally ill cancer patients. Palliative medicine, pp.9-375, 1998.

W. Meissner, P. Leyendecker, S. Mueller-lissner, J. Nadstawek, M. Hopp et al., A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation, European Journal of Pain, vol.22, issue.1, pp.56-64, 2008.
DOI : 10.1177/104990910502200511

D. Vondrackova, P. Leyendecker, W. Meissner, M. Hopp, I. Szombati et al., Analgesic Efficacy and Safety of Oxycodone in Combination With Naloxone as Prolonged Release Tablets in Patients With Moderate to Severe Chronic Pain, The Journal of Pain, vol.9, issue.12
DOI : 10.1016/j.jpain.2008.06.014

R. Ville-de, Code postal

!. Syk, Stnuégie de prise en charge des effets indésirables liés aux traitements antalgiques par morphiniques

S. Relislor, utilisation d'un nouveau traitement contre la constipation au service d'oncologie du CHR de MelZ